Kiora Pharmaceuticals (KPRX) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free KPRX Stock Alerts $0.50 -0.01 (-1.96%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Kiora Pharmaceuticals Short Interest DataCurrent Short Volume135,000 sharesPrevious Short Volume73,400 sharesChange Vs. Previous Month+83.92%Dollar Volume Sold Short$68,850.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares26,260,000 sharesFloat Size23,950,000 sharesShort Percent of Float0.56%Today's Trading Volume108,845 sharesAverage Trading Volume1,167,418 sharesToday's Volume Vs. Average9% Short Selling Kiora Pharmaceuticals ? Sign up to receive the latest short interest report for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKPRX Short Interest Over TimeKPRX Days to Cover Over TimeKPRX Percentage of Float Shorted Over Time Ad Stocks NewsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarRevolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 Kiora Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024135,000 shares $68,850.00 +83.9%0.6%0.5 $0.51 4/15/202473,400 shares $41,104.00 +48.3%0.3%0 $0.56 3/31/202449,500 shares $34,947.00 -42.7%0.7%0 $0.71 3/15/202486,400 shares $55,218.24 +51.6%1.2%0.1 $0.64 2/29/202457,000 shares $38,247.00 -65.4%0.8%0 $0.67 2/15/2024164,500 shares $103,914.65 -53.0%2.2%0.1 $0.63 Get the Latest News and Ratings for KPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiora Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024349,800 shares $193,229.52 -2.3%5.0%0.2 $0.55 1/15/2024358,100 shares $189,649.76 +1.9%5.1%4 $0.53 12/31/2023351,300 shares $183,519.12 -7.1%5.0%3.7 $0.52 12/15/2023378,300 shares $203,147.10 -18.0%5.4%3.8 $0.54 11/30/2023461,100 shares $238,527.03 -14.6%6.6%4.5 $0.52 11/15/2023539,900 shares $312,008.21 +67.3%7.8%4.7 $0.58 10/31/2023322,700 shares $191,683.80 +15.0%4.9%1.1 $0.59 10/15/2023280,600 shares $179,291.90 +4.9%4.3%1 $0.64 9/30/2023267,400 shares $151,802.98 +5.9%4.1%0.9 $0.57 9/15/2023252,600 shares $136,151.40 -30.6%3.8%0.8 $0.54 8/31/2023364,200 shares $179,113.56 +398.9%5.4%1 $0.49 8/15/202373,000 shares $40,880.00 -17.9%1.0%0.2 $0.56 7/31/202388,900 shares $52,451.00 No Change1.3%0.3 $0.59 7/15/202388,900 shares $56,451.50 +15.9%1.3%0.3 $0.64 6/30/202376,700 shares $49,310.43 -37.4%1.3%0.3 $0.64 6/15/2023122,500 shares $98,000.00 -33.4%2.2%0.6 $0.80 5/31/2023183,900 shares $386,190.00 +99.9%3.3%1.1 $2.10 5/15/202392,000 shares $216,200.00 +0.7%5.2%1.3 $2.35 4/30/202391,400 shares $405,816.00 +13.4%5.4%0.1 $4.44 4/15/202380,600 shares $334,627.02 -15.0%4.7%0.1 $4.15 3/31/202394,800 shares $316,632.00 +96.3%5.6%0.1 $3.34 3/15/202348,300 shares $178,227.00 -66.6%2.9%0 $3.69 2/28/2023144,500 shares $643,025.00 -53.5%8.7%0.1 $4.45 2/15/2023310,600 shares $1.69 million +354.8%18.7%0.2 $5.45 1/31/202368,300 shares $241,099.00 -47.1%4.3%0 $3.53 1/15/2023129,000 shares $476,010.00 +737.7%8.2%0.5 $3.69 12/30/202215,400 shares $52,822.00 -34.2%1.1%0 $3.43 12/15/202223,400 shares $79,326.00 -18.8%2.5%0 $3.39 11/30/202228,800 shares $102,240.00 -51.0%3.1%0.1 $3.55 11/15/202258,800 shares $363,384.00 -30.6%6.4%0.1 $6.18 10/31/202284,700 shares $556,479.00 +3.4%9.8%0.1 $6.57 10/15/202281,900 shares $504,504.00 -42.7%9.2%0.1 $6.16 9/30/2022142,800 shares $878,220.00 -97.6%N/A0.4 $6.15 9/15/20225,900,000 shares $1.33 million -16.7%N/A0.6 $0.22With revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 KPRX Short Interest - Frequently Asked Questions What is Kiora Pharmaceuticals' current short interest? Short interest is the volume of Kiora Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 135,000 shares of KPRX short. 0.56% of Kiora Pharmaceuticals' shares are currently sold short. Learn More on Kiora Pharmaceuticals' current short interest. What is a good short interest percentage for Kiora Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.56% of Kiora Pharmaceuticals' floating shares are currently sold short. Is Kiora Pharmaceuticals' short interest increasing or decreasing? Kiora Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 135,000 shares, an increase of 83.9% from the previous total of 73,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kiora Pharmaceuticals' float size? Kiora Pharmaceuticals currently has issued a total of 26,260,000 shares. Some of Kiora Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kiora Pharmaceuticals currently has a public float of 23,950,000 shares. How does Kiora Pharmaceuticals' short interest compare to its competitors? 0.56% of Kiora Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kiora Pharmaceuticals: Purple Biotech Ltd (1.18%), Eterna Therapeutics Inc. (1.15%), RedHill Biopharma Ltd. (2.38%), Imunon, Inc. (3.95%), Pieris Pharmaceuticals, Inc. (1.12%), FSD Pharma Inc. (1.00%), Edesa Biotech, Inc. (0.69%), Akari Therapeutics, Plc (0.03%), Monopar Therapeutics Inc. (1.24%), ABVC BioPharma, Inc. (7.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Kiora Pharmaceuticals stock? Short selling KPRX is an investing strategy that aims to generate trading profit from Kiora Pharmaceuticals as its price is falling. KPRX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kiora Pharmaceuticals? A short squeeze for Kiora Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KPRX, which in turn drives the price of the stock up even further. How often is Kiora Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KPRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PPBT Short Interest ERNA Short Interest RDHL Short Interest IMNN Short Interest PIRS Short Interest HUGE Short Interest EDSA Short Interest AKTX Short Interest MNPR Short Interest ABVC Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KPRX) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable Prosperity